| Gregory Olyansky, | |
|
1200 Old York Rd, Abington, PA 19001-3720 | |
| (215) 481-2000 | |
| Not Available |
| Full Name | Gregory Olyansky |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1200 Old York Rd, Abington, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134999592 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN681266 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Olyansky, 528 E Pine St, Feasterville Trevose, PA 19053-4524 Ph: (267) 471-4864 | Gregory Olyansky, 1200 Old York Rd, Abington, PA 19001-3720 Ph: (215) 481-2000 |
News Archive
"Snoring, sleep apnoea, and obesity-related respiratory difficulties are fairly common disorders that affect a large proportion of the population," according to Poul Jennum, Professor of Clinical Neurophysiology at the Center for Healthy Ageing at the University of Copenhagen Faculty of Health Sciences. He is head of the Danish Centre for Sleep Medicine, Glostrup Hospital, which treats patients from all over the country.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced the call for submissions for its new open access journal Heliyon.
The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available on the market, e.g. ECL.
The American Medical Group Association announced significant accomplishments in its advocacy efforts to reward members for the high level of quality, cost-efficient, coordinated care they bring to their communities with the inclusion of language establishing Accountable Care Organizations in the recently passed health reform legislation.
Gilead Sciences, Inc. today announced that DAR-312 (DORADO-AC), a Phase III clinical trial evaluating darusentan, the company's endothelin receptor antagonist (ERA) for the treatment of resistant hypertension, did not achieve its co-primary efficacy endpoints of change from baseline to week 14 in trough sitting systolic blood pressure (SBP) and diastolic blood pressure (DBP) compared to placebo.
› Verified 1 days ago
Irene A. Ahorlu, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Rachel Landgraf, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Paul Douglass, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Rachel Yashin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2336 | |
Lisamarie Meagher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Martin J Nolan, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 |